HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men
2020| Liver International |In Press


Drug related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
2020| International Journal of Drug Policy |In Press


A computable phenotype model for classification of men who have sex with men within a large linked database of laboratory, surveillance, and administrative healthcare records
2020| Frontiers in Digital Health |In Press


Syndemic Profiles of people living with hepatitis C virus using population-level latent class analysis: informing optimal integration of health services
2020| International Journal of Infectious Diseases |Available Online


Concurrent hepatitis C and B virus and HIV infections are associated with higher mortality risk illustrating the impact of the syndemics on health outcomes
2020| Open Forum Infectious Diseases |In Press


Real world effectiveness of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection: A population-based cohort study
2020| Open Forum Infectious Diseases |Available Online


Comparing direct acting antivirals for hepatitis C using observational data - why and how?
2020| Pharamacology Research and Perspectives |In Press


The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk
2020| Journal of Viral Hepatitis |Available Online

Using population-level integrated health data to monitor and assess patients’ progression across care and treatment continuums
2019| BC Medical Journal |Available Online


The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of Direct Acting Antivirals.
2019| Liver International |Available Online


What is Killing People with Hepatitis C Virus Infection? Analysis of a population-based cohort in Canada
2019| International Journal of Drug Policy |In Press


Sustained Virologic Response from Interferon-based Hepatitis C Treatments associated with Reduced Extrahepatic Manifestations Risk
2019| Journal of Hepatology |In Press

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatatsvir in People who inject drugs and/or those in Opioid Agonist Therapy
2018| Hepatitis Communications |Available Online


Contextualizing Canada's Hepatitis C Virus Epidemic
2018| Canadian Liver Journal | Available Online


Applying core theory and spatial analysis to identify HCV infection 'core areas' in British Columbia, Canada
2018| Journal of Viral Hepatitis | Available Online


Effect of  opioid subistution therapy (OST) and psychotherapy on HIV risk among HCV infected individuals
2018| Clinical Epidemiology | Available Online


Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.
2018| Journal of Viral Hepatitis | Available Online


Syndemic characterization of HCV, HBV, and HIV co-infections in a large population based cohort study
2018| E Clinical Medicine | Available Online


Real-world effectiveness of sofosbuvir-based regimens for Hepatitis C treatment among people who inject drugs and/or those in opioid substitution therapy in Canada
2018| Hepatology Communications |In Press


Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy on a large population based cohort
2018| Journal of Hepatology | Available Online Lay Summary


Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
2018| World Journal of Gastroenterology| Available OnlineLay Summary


Identifying Injection Drug Use and Estimating Population size of people who inject drugs using healthcare administrative datasets
2018| International Journal of Drug Policy| Available Online


Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison
2018|Journal of Viral Hepatitis| Available Online

The contribution of alcohol-use to decompensated cirrhosis among people with hepatitis C: an international study
2017| Journal of Hepatology| Available Online


A Syndemic Approach to assess the effect of Substance Use and Social Disparities’ on the evolution of HIV/HCV infections in British Columbia. 
2017| PLOS ONE| Available Online| Lay Summary


Hepatitis C cross-genotype immunity and implications for vaccine development.
2017|Scientific Report|Available Online


Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development
2017|Journal of Hepatology| Available Online | Lay Summary


Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study
2017|The Lancet Gastroenterology & Hepatology| Available Online

Assessing hepatitis C burden and treatment effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): design and characteristics of linked and unlinked participants.
2016|PLOS ONE| Available Online


Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis
Testers Cohort

2016| BMC Infectious Diseases| Available Online


The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
2016|Ebiomedicine| Available Online


Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada
2016|Journal of Hepatology| Available Online


Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of Hepatitis C: The BC Hepatitis Testers Cohort. 
2016|Journal of Viral Hepatology| Available Online


Shift in disparities in Hepatitis C treatment form interferon to DAA: A population-based cohort study.
2016| Journal of Viral Hepatology| Available Online